Showing results (1-10 of 100) with videos related to
Sort By:
Pageof 10
FEMS Immunology and Medical Microbiology|July 2, 2003
Identification of the domains of the fibronectin-binding protein I of Streptococcus pyogenes responsible for adjuvanticityKai Schulze, Carlos A GuzmánVaccine|November 18, 2005
Intranasal immunization with serum opacity factor (SOF) of Streptococcus pyogenes fails to protect mice against lethal mucosal challenge with a heterologous strainKai Schulze, Eva Medina, Carlos A GuzmánExpert Review of Vaccines|August 14, 2015
Rodents as pre-clinical models for predicting vaccine performance in humansPeggy Riese, Stephanie Trittel, Kai Schulze, et al.International Journal of Medical Microbiology : IJMM|September 22, 2007
The FAI protein of group C streptococci acts as a mucosal adjuvant by the specific targeting and activation of B cellsKai Schulze, Oliver Goldmann, Eva Medina, et al.Vaccine|July 11, 2006
Intranasal vaccination with SfbI or M protein-derived peptides conjugated to diphtheria toxoid confers protective immunity against a lethal challenge with Streptococcus pyogenesKai Schulze, Colleen Olive, Thomas Ebensen, et al.Infection and Immunity|November 26, 2003
Identification of B- and T-cell epitopes within the fibronectin-binding domain of the SfbI protein of Streptococcus pyogenesKai Schulze, Eva Medina, Gursharan S Chhatwal, et al.Vaccine|April 23, 2003
Stimulation of long-lasting protection against Streptococcus pyogenes after intranasal vaccination with non adjuvanted fibronectin-binding domain of the SfbI proteinKai Schulze, Eva Medina, Gursharan S Chhatwal, et al.The Lancet. Infectious Diseases|October 8, 2019
A governance framework for development and assessment of national action plans on antimicrobial resistanceMichael Anderson, Kai Schulze, Alessandro Cassini, et al.Frontiers in Cellular and Infection Microbiology|March 7, 2019
The Combination Vaccine Adjuvant System Alum/c-di-AMP Results in Quantitative and Qualitative Enhanced Immune Responses Post ImmunizationThomas Ebensen, Simon Delandre, Blair Prochnow, et al.Vaccine|January 22, 2005
The FAI protein of group C streptococci targets B-cells and exhibits adjuvant activityKai Schulze, Oliver Goldmann, Antonia Toppel, et al.Pageof 10